Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Wait, it's 'Harry Potter and the Philosopher's Stone'? Why the new HBO series name is significant to Americans - 2Iran-backed militias reassert power in Iraq, proving the Islamic axis is still standing
- 3Former school bus aide pleads guilty to assaulting 3 autistic students in Colorado
- 4Newly Identified ‘Lucy’s Hunter’ Was a 15-Foot Crocodile Lurking in Ancient Ethiopia
- 5The Leonid meteor shower is peaking early this week. Here’s what to know
- FDA official discusses potential link between COVID-19 vaccines and pediatric deaths
- Independence from the rat race: How to Save and Contribute Shrewdly
- I read 115 books this year. 'Wuthering Heights,' 'Heart the Lover' and 'The House of My Mother' were among my 10 favorites.
- From Squid Game to Your Party! Six Entertaining Test Games That Will Have You in Join
- Verdicts against social media companies carry consequences. But questions linger
- Which Espresso Do You Like Best? Vote
- Visiting This Japanese City Just Got A Little More Expensive (Here's What Travelers Should Know)
- Los Angeles County sees significant uptick in norovirus cases, officials say
- Doulas play essential roles in reproductive health care – and more states are beginning to recognize it
